Solventum Corp

SOLV: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
b<LOCK|BVKLOCK|vP>D&^X

Solventum Earnings: Strong Medical-Surgical Growth Lifts the Firm as It Plans to Separate HIS Segment

Solventum posted second-quarter revenue of $2.2 billion, up 2% year over year. Quarterly operating income of $627 million rose 32% after adjusting for amortization, separation costs from 3M, and litigation.

Sponsor Center